NCT04628208View on ClinicalTrials.gov

Clinical Study Spartan COVID-19 V2 System (Canada Alternate)

CompletedOBSERVATIONAL
Enrollment

81

Participants

Timeline

Start Date

November 17, 2020

Primary Completion Date

December 7, 2020

Study Completion Date

December 7, 2020

Conditions
Covid19
Interventions
DIAGNOSTIC_TEST

Spartan COVID-19 v2 System

A nasopharyngeal swab sample analyzed on the Spartan COVID-19 v2 System for the detection of SARS-CoV-2.

Trial Locations (1)

K1Y4E9

The Ottawa hospital, Ottawa

All Listed Sponsors
lead

Spartan Bioscience Inc.

INDUSTRY

NCT04628208 - Clinical Study Spartan COVID-19 V2 System (Canada Alternate) | Biotech Hunter | Biotech Hunter